Novartis Buys Avrobio’s Rare Disease Gene Therapy for US$87.5 M
By Lucy Haggerty
Pharma Deals Review: Vol 2023 Issue 6 (Table of Contents)
Published: 8 Jun-2023
DOI: 10.3833/pdr.v2023.i6.2790 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In order to bolster its gene therapy pipeline, Novartis has agreed to pay US$87...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS